骨髓增生异常综合征 myelodysplastic syndrome ; MDS ; RCMD ; myelodysplastic syndromes MDS
骨髓异常增生综合征 MDS ; myelodysplastic syndrome
例骨髓增生异常综合征 myelodgsplastic syndrome
测骨髓增生异常综合征 myelodysplastiesyndrome
的骨髓增生异常综合征 myelodyplastic syndrome
危骨髓增生异常综合征 myelodysplastic syndrome
在骨髓增生异常综合征 myelodysplastic syndrome
骨髓增生异样综合征 myelodysplastic syndrome
骨髓增生失常综合征 myelodysplasticSy Ndrome
他的团队探讨骨髓增生异常综合征的患者血红蛋白合成异常的情况。
His team investigated the state of abnormal composition of hemoprotein in myelodysplastic syndrome.
Revlimid和类固醇地塞米松联合用药被批准用于多发性脊髓瘤和罕见病 骨髓增生异常综合征 的治疗。 其2009年的销售额为17亿美元。
Revlimid, which is approved for multiple myeloma patients in combination with the steroid dexamethasone, and for a rare condition called myelodysplastic syndromes, had revenue of $1.7 billion in 2009.
氮杂胞苷（Azacitidine），用于治疗骨髓增生异常综合征（MDS） 一种罕见的恶性血液肿瘤。
Azacitidine is used to treat patients with myelodysplastic syndromes (usually abbreviated, a bit oddly, to MDS), a group of rare and deadly blood malignancies.
应用推荐